Clinical Trial Update: OSPM-Enhanced AI Model to Identify Premalignant and Malignant Ocular Surface Tumors

View source ↗

Summary

A completed clinical trial evaluating an OSPM-enhanced AI model for identifying premalignant and malignant ocular surface tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Surface Squamous Neoplasia

Snippet

Sponsor: Ningbo Eye Hospital | Conditions: Performance of the Model | Status: COMPLETED